Organon & Co. (NYSE:OGN) Downgraded by The Goldman Sachs Group to Neutral
The Goldman Sachs Group lowered shares of Organon & Co. (NYSE:OGN – Free Report) from a buy rating to a neutral rating in a report published on Friday, MarketBeat.com reports. The Goldman Sachs Group currently has $16.00 target price on the stock, down from their previous target price of $33.00. Other research analysts also recently […]
More Stories
West Oak Capital LLC Buys 885,093 Shares of JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST)
West Oak Capital LLC lifted its stake in JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST – Free Report) by 2,619.5% during the...
West Oak Capital LLC Has $276,000 Holdings in JPMorgan Chase & Co. (NYSE:JPM)
West Oak Capital LLC trimmed its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 94.6% in the fourth...
West Oak Capital LLC Has $182,000 Stake in TransUnion (NYSE:TRU)
West Oak Capital LLC grew its position in TransUnion (NYSE:TRU – Free Report) by 684.0% during the 4th quarter, according...
West Oak Capital LLC Lowers Position in Schwab US Large-Cap ETF (NYSEARCA:SCHX)
West Oak Capital LLC decreased its position in shares of Schwab US Large-Cap ETF (NYSEARCA:SCHX – Free Report) by 78.2%...
HEICO Co. (NYSE:HEI) Shares Bought by West Oak Capital LLC
West Oak Capital LLC lifted its stake in HEICO Co. (NYSE:HEI – Free Report) by 2,400.0% during the fourth quarter,...
West Oak Capital LLC Has $1.42 Million Stock Position in Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)
West Oak Capital LLC raised its position in shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM – Free Report) by...